On a GLP-1? Here's Why EvolveX Should Be Part of Your Protocol

GLP-1 receptor agonists — medications like semaglutide and tirzepatide — have genuinely changed what's possible for patients managing their weight. The results can be dramatic. But there's a tradeoff that doesn't always make it into the conversation during your first prescription: you're not just losing fat. You're likely losing muscle too.

For patients at Hi, Finch, this is one of the most common concerns that comes up once the initial excitement of GLP-1 weight loss settles in. The scale is moving, but something doesn't feel right. Clothes fit differently, but strength is down. That's not a personal failure — it's physiology. And it's exactly the problem EvolveX was built to address.

What GLP-1 Medications Actually Do to Your Body Composition

GLP-1 medications work by mimicking a naturally occurring hormone that regulates appetite and blood sugar. They slow gastric emptying, reduce hunger signals, and help your body use insulin more effectively. The result: most patients eat significantly less, and weight loss follows.

The issue is that significant caloric restriction — regardless of the cause — triggers the body to break down muscle tissue alongside fat. Research suggests that without active intervention, muscle loss can account for up to 25–40% of total weight lost during aggressive caloric restriction. That's not a small number.

Muscle loss matters beyond aesthetics. Skeletal muscle plays a central role in metabolic rate, insulin sensitivity, joint stability, and functional strength. Losing it during GLP-1 therapy can undermine the very metabolic outcomes the medication is trying to achieve — and it can leave patients looking softer or feeling weaker than they expected, even at a lower weight.

This is where body contouring with EvolveX enters the picture — not as a cosmetic add-on, but as a clinically rational part of your weight management protocol.

What EvolveX Is and How It Works

EvolveX is a non-invasive body contouring platform by InMode that uses two core modalities — radiofrequency (RF) energy and electrical muscle stimulation (EMS) — to address body composition from multiple angles in the same session.

What we love about EvolveX is exactly this: it burns fat, tightens skin, and builds muscle simultaneously. At Hi, Finch, we use it most commonly for the abdomen and legs — the areas most affected by the muscle wasting that accompanies GLP-1 therapy.

Here's what each component does:

Radiofrequency (RF)

Delivers controlled thermal energy to the subdermal tissue, heating fat cells and stimulating collagen remodeling in the skin. The heat disrupts fat while simultaneously tightening the overlying skin — which is especially important for patients experiencing skin laxity from rapid weight loss.

Electrical Muscle Stimulation (EMS)

Sends electrical impulses directly into the muscle, triggering involuntary contractions that mimic the effect of high-intensity exercise at a neuromuscular level. Over a series of treatments, this stimulates muscle fiber recruitment and contributes to measurable improvements in muscle density and definition.

Together, RF and EMS do what GLP-1 therapy alone cannot: they work at the tissue level to reshape your body composition rather than simply reduce it.

Why the Legs and Abdomen Are Priority Areas

Nashville patients on GLP-1 medications frequently report two specific concerns: abdominal softness — sometimes described as loss of muscle definition through the core — and changes in the legs, particularly the inner thighs and quadriceps, where muscle wasting is often most visible.

Both areas respond well to EvolveX for different reasons.

The abdomen is a metabolically active area where fat loss can be uneven and skin laxity sets in quickly with rapid weight reduction. EvolveX's RF component heats and disrupts the underlying fat while tightening the overlying skin, and the EMS works the rectus abdominis and obliques — the muscles that give the midsection its shape and structural support.

The legs — particularly the thighs — are high-muscle-mass areas that are especially vulnerable to atrophy during caloric restriction. EvolveX applicators can target the quadriceps, hamstrings, and inner thigh, stimulating contractions that support muscle maintenance and help restore the definition that weight loss alone may have diminished.

We recommend eight sessions — one session per week for eight weeks — for patients actively on GLP-1 therapy.

When to Start EvolveX on a GLP-1 Protocol

This is one of the most common questions we get at our Nashville practice, and the honest answer is: sooner than most patients think.

Many people wait until they've reached their goal weight to think about body contouring. That's understandable — it feels like putting the cart before the horse. But from a muscle preservation standpoint, waiting until weight loss is complete means you've already lost the muscle you were trying to protect.

Ideally, EvolveX treatment begins within the first few months of GLP-1 therapy, once your body has started responding to the medication and your weight is actively shifting. Starting early means the EMS component can work in parallel with your weight loss — actively stimulating muscle tissue at the same time your caloric intake is reduced.

For patients who are already further along in their GLP-1 journey, EvolveX is still highly appropriate — the goal shifts slightly toward rebuilding and redefining rather than purely preserving, but the treatment rationale is identical.

Your provider at Hi, Finch will assess your current stage of treatment, your specific areas of concern, and what a realistic eight-week series looks like for your body and timeline.

Frequently Asked Questions

Does EvolveX hurt?

Most patients describe EvolveX as intense but tolerable — the muscle stimulation feels like a strong workout contraction, and the RF generates noticeable warmth in the tissue. Discomfort levels vary by treatment area and individual sensitivity, but the majority of patients complete sessions comfortably. There's no downtime; most people return to normal activity immediately.

How many EvolveX sessions do I need if I'm on a GLP-1?

We recommend eight sessions, scheduled once per week for eight weeks. This cadence gives the RF and EMS enough cumulative stimulus to produce meaningful changes in fat, skin, and muscle — while aligning with the active phase of GLP-1 weight loss where preservation and recomposition matter most.

Can EvolveX replace exercise while I'm on a GLP-1?

EvolveX is not a substitute for physical activity — it's a clinical tool that works best as part of a broader protocol that includes resistance training when possible. That said, many GLP-1 patients experience fatigue or reduced appetite that makes traditional exercise harder to maintain consistently. EvolveX can provide meaningful muscle stimulus during periods when activity is limited, and it pairs well with whatever level of movement you're currently able to do.

Will EvolveX help with loose skin from weight loss?

The radiofrequency component of EvolveX delivers controlled heat to the subdermal tissue, stimulating collagen and elastin remodeling that can visibly tighten skin over the course of treatment. For mild to moderate skin laxity accompanying GLP-1 weight loss, many patients see meaningful improvement. Severe skin laxity may require additional treatment modalities, which your provider can discuss during consultation.

Is EvolveX right for everyone on a GLP-1?

EvolveX is appropriate for most adults who are medically stable and actively losing weight on a GLP-1 medication. It is not recommended for patients with certain implanted devices (including pacemakers), active skin infections in the treatment area, or during pregnancy. A provider consultation will confirm whether it's the right fit for you.

GLP-1 therapy is one of the most effective tools we have for sustainable weight management — and EvolveX is how we make sure the body you're working toward is the one you actually get. If you're in Nashville and you're ready to talk about adding body contouring to your protocol, book a consultation at hifinch.com.

 

References

Colleluori G, Villareal DT. Obesity, type 2 diabetes, and caloric restriction: the obesity paradox and aging. Ageing Research Reviews. 2021;66:101245. doi:10.1016/j.arr.2021.101245

Alissou M, Demangeat T, Folope V, et al. Impact of semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study. Diabetes, Obesity & Metabolism. 2025;28(1):112-121. doi:10.1111/dom.70141

Dayan E, Burns AJ, Rohrich RJ, Theodorou S. The use of radiofrequency in aesthetic surgery. Plastic and Reconstructive Surgery — Global Open. 2020;8(8):e2861. doi:10.1097/GOX.0000000000002861